41 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
for the manufacture of drug substance, the manufacture of drug product, and the packaging of drug product for clinical use. This reliance on contract … change, the methods used and the facilities and controls used for the manufacture, processing, packaging, or holding of human drugs must comply
8-K/A
EX-99.2
azk9 27ja3fpkiqtxq6y
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
roluvh9dtfq3z8o
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
hxt5wdejyzuepv0kttl
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
oj7d cw5f
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
1xg6w3vdj qdtj
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
5ygm dpnrck9kn5vf2
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
kpceisv50ls1 pp5j
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-1.1
890mlnz
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-10.1
2qzci1i7wh1es adj
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
m4taq kuc
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
rvkyrlmnu
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm